Global Biobanking Market By Type (Equipment, and Consumable), By Application (Virtual Biobanks, Tissue Biobanks, and Population Biobanks), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 133955
- 12-Dec
- PDF/PPT/Word
-
Report Details
The report on Biobanking Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global biobanking market is segmented on the basis of Type, Application, and geography.
The global Biobanking market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.Biobanking Market Scope:
By type, the market is segmented into Equipment, and Consumable. By Application, the market is divided into Virtual Biobanks, Tissue Biobanks, and Population Biobanks. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Beckman Coulter, Thermo Fisher, Panasonic, Sigma-Aldrich, SOL Group, Promega, BD, Brooks Life Science, QIAGEN, Tecan Group, Lifeline Scientific, So-Low, LVL Technologies, DNA Genotek, Micronic, Askion, Biolife Solutions, Cryo Bio System, and BioRep.
Key Market Segments
Type
Equipment
ConsumableApplication
Virtual Biobanks
Tissue Biobanks
Population BiobanksKey Market Players included in the report:
Beckman Coulter
Thermo Fisher
Panasonic
Sigma-Aldrich
SOL Group
Promega
BD
Brooks Life Science
QIAGEN
Tecan Group
Lifeline Scientific
So-Low
LVL Technologies
DNA Genotek
Micronic
Askion
Biolife Solutions
Cryo Bio System
BioRepReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Biobanking Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Biobanking Market, high-growth regions, and market drivers, restraints, and also market chances.
The analysis covers Biobanking Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Biobanking Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Biobanking Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Biobanking Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Biobanking sub-markets, depending on key regions (various vital states).
To analyze Biobanking Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Biobanking Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
Primary worldwide Biobanking Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Biobanking Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Biobanking Market Overview3.1. Biobanking Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Biobanking Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Biobanking Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Equipment
4.4. Consumable5. Global Biobanking Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Biobanking Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Virtual Biobanks
5.4. Tissue Biobanks
5.5. Population Biobanks6. Global Biobanking Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Biobanking Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2. Europe
6.2.1. Europe Biobanking Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Biobanking Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Biobanking Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Biobanking Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Biobanking Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Beckman Coulter7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Thermo Fisher7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Panasonic7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Sigma-Aldrich7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. SOL Group7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Promega7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. BD7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Brooks Life Science7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. QIAGEN7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. Tecan Group7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments7.13. Lifeline Scientific7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments7.14. So-Low7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments7.15. LVL Technologies7.15.1. Company Overview
7.15.2. Financial Highlights
7.15.3. Product Portfolio
7.15.4. SWOT Analysis
7.15.5. Key Strategies and Developments7.16. DNA Genotek7.16.1. Company Overview
7.16.2. Financial Highlights
7.16.3. Product Portfolio
7.16.4. SWOT Analysis
7.16.5. Key Strategies and Developments7.17. Micronic7.17.1. Company Overview
7.17.2. Financial Highlights
7.17.3. Product Portfolio
7.17.4. SWOT Analysis
7.17.5. Key Strategies and Developments7.18. Askion7.18.1. Company Overview
7.18.2. Financial Highlights
7.18.3. Product Portfolio
7.18.4. SWOT Analysis
7.18.5. Key Strategies and Developments7.19. Biolife Solutions7.19.1. Company Overview
7.19.2. Financial Highlights
7.19.3. Product Portfolio
7.19.4. SWOT Analysis
7.19.5. Key Strategies and Developments7.20. Cryo Bio System7.20.1. Company Overview
7.20.2. Financial Highlights
7.20.3. Product Portfolio
7.20.4. SWOT Analysis
7.20.5. Key Strategies and Developments7.21. BioRep7.21.1. Company Overview
7.21.2. Financial Highlights
7.21.3. Product Portfolio
7.21.4. SWOT Analysis
7.21.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
